Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
JAMA Network Open|July 16, 2020
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical TrialGiacomo Koch, Caterina Motta, Sonia Bonnì, et al.
Molecular Pharmacology|April 29, 2010
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibitionSilvia Rossi, Valentina De Chiara, Alessandra Musella, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2010
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosisFrancesco Mori, Silvia Rossi, Giulia Sancesario, et al.
Brain, Behavior, and Immunity|April 9, 2011
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitisSilvia Rossi, Roberto Furlan, Valentina De Chiara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Acta Neuropathologica|April 30, 2015
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNSBenedetta Parodi, Silvia Rossi, Sara Morando, et al.
Scientific Reports|October 25, 2017
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's diseaseGiacomo Koch, Francesco Di Lorenzo, Stefano Loizzo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitisAntonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Clinical Science (London, England : 1979)|February 21, 2015
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosisGabriella Ruocco, Silvia Rossi, Caterina Motta, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Pageof 9